A putative role for c-Fos in the pathophysiology of Paget's disease

Journal of Bone and Mineral Research

Volumn 14, Issue SUPPL. 2, 1999, Pages 21-28

  Beedles, Karen E ^a   Sharpe, Paul T ^a   Wagner, Erwin F ^b   Grigoriadis, Agamemnon E ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; GELATINASE B; PROTEIN C FOS;

ANIMAL MODEL; ANIMAL TISSUE; BONE REMODELING; BONE TURNOVER; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; HISTOPATHOLOGY; MALIGNANT TRANSFORMATION; MOUSE; MULTINUCLEAR CELL; NONHUMAN; ONCOGENE C FOS; OSTEOCLAST; OSTEOSARCOMA; PAGET BONE DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ACID PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; CHONDROCYTES; IN SITU HYBRIDIZATION; ISOENZYMES; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; OSTEITIS DEFORMANS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 0032831398     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.1.21     Document Type: Conference Paper

References (24)

1. Kanis JA 1991 The Pathophysiology and Treatment of Paget's Disease. Martin Dunitz, London, U.K.
2. Hoyland JA, Freemont AJ, Sharpe PT 1994 Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res 9:75-80.
3. Mee AP, Sharpe PT 1993 Dogs, distemper and Paget's disease. Bioessays 15:783-789.
4. Cody JD, Singer FR, Roodman GD, Otterund B, Lewis TB, Leppert M, Leach RJ 1997 Genetic linkage of Paget's disease of the bone to chromosome 18q. Am J Hum Genet 61:1117-1122.
5. Haslam SI, Van Hul W, Morales-Piga A, Balemans W, San-Millan JL. Nakatsuka K, Willems P, Haites NE, Ralston SH 1998 Paget's disease of bone: Evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. J Bone Miner Res 13:911-917.
6. Haslam SI, Haites NE, Thomson JMG, Nakatsuka K, Ralston SH 1997 Genetics of Paget's disease: Linkage to chromosome 18q and evidence of abnormal Bcl-2 regulation. Bone 20:4S, 9S.
7. Hoyland J, Sharpe PT 1994 Upregulation of c-Fos protooncogene expression in Pagetic osteoclasts. J Bone Miner Res 9:1191-1194.
8. Grigoriadis AE, Wang Z-Q, Wagner EF 1995 Fos and bone cell development: Lessons from a nuclear oncogene. Trends Genet 11:436-441.
9. Angel P, Karin M 1991 The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157.
10. Grigoriadis AE, Schellander K, Wang Z-Q, Wagner EF 1993 Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122:685-701.
11. Rüther U, Garber C, Komitowski D, Müller R, Wagner EF 1987 Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 325:412-416.
12. Rüther U, Komitowski D, Schubert FR, Wagner EF 1989 c-fos expression induces bone tumors in transgenic mice. Oncogene 4:861-865.
13. Wang Z-Q, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF 1992 Bone and haematopoietic defects in mice lacking c-fos. Nature 360:741-745.
14. Grigoriadis AE, Wang Z-Q, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF 1994 c-Fos is a key regulator of osteoclast/macrophage lineage determination and bone remodeling. Science 266:443-448.
15. Boyce BF, Wright K, Reddy SV, Koop BA, Story B, Devlin R, Leach RJ, Roodman GD, Windle JJ 1995 Targeting simian-virus-40 T-antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts. Endocrinology 136:5751-5759.
16. Schwartzberg PL, Xing LP, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE 1997 Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/-mutant mice. Genes Dev 11:2835-2844.
17. Hentunen TA, Reddy SV, Boyce BF, Devlin R, Park HR, Chung HY, Selander KS, Dallas M, Kurihara N, Galson DL, Goldring SR, Koop BA, Windle JJ, Roodman GD 1997 Immortalization of osteoclast precursors by targeting bcl-X-L and simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest 102:88-97.
18. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K 1994 Expression of 92-kd type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124:1091-1102.
19. Grigoriadis AE, Wang Z-Q, Wagner EF 1993 c-fos oncogene expression in cartilage and bone tissues of transgenic and chimeric mice. In: Noda M, (ed.) Molecular and Cellular Biology of Bone. Academic Press, Orlando, FL, U.S.A., pp. 497-537.
20. Sunters A, McCluskey J, Grigoriadis AE 1998 Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation. Dev Genet 22:386-397.
21. Wang Z-Q, Grigoriadis AE, Möhle-Steinlein U, Wagner EF 1991 A novel target cell for c-fos-induced oncogenesis: Development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J 10:2437-2450.
22. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
23. Kong Y-Y, Yoshida H, Sarosi I, Tan H-L, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJG, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclasto-genesis, lymphocyte development and lymph node organogenesis. Nature 397:315-323.
24. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.